Welcome visitor Log In - or - Register
(
0 items /
$0.00
)
View Cart
Check Out
four ways
Quick Search:
Skip Navigation LinksHome > Glutaminase Inhibitor > CB-839 (Telaglenastat)
CB-839 (Telaglenastat)
CB-839 (Telaglenastat) is a clinical-stage, orally bioavailable inhibitor of the glutaminase 1 (GLS1) splice variants, kidney-type (KGA) and glutaminase C (GAC). It inhibits human recombinant GAC (IC50 < 50 nM), and GLS1 activity in tissue homogenates (IC50s = 28 and 23 nM, respectively for brain and kidney), but not GLS2 (IC50 > 1,000 nM from liver). Displays antiproliferative activity against the triple-negative breast cancer (TNBC) cell lines HCC1806 and MDA-MB-231 (IC50s = 49 and 26 nM, respectively) but not against estrogen receptor-positive T47D cells (IC50 > 1,000 nM). In a patient-derived TNBC mouse xenograft model, CB-839 (200 mg/kg, p.o.) inhibits tumor growth by 61% relative to vehicle control. It also possesses antiproliferative properties in vitro against acute myeloid leukemia (AML) and in synergy with erlotinib (Prod No. CT-EL002) in EGFR-driven non-small cell lung cancer (NSCLC) in vitro and in xenografts (ref 1, 2, 3).
Catalog NO: CT-CB839
Synonym: CB839, Telaglenastat
CAS NO: 1439399-58-2
Mol. Formula: C26H24F3N7O3S
MW: 571.6
** in vivo Quality Material. 99.9% Purity, recrystallized off-white crystalline solid (see attached Quality Controls). Anhydrous, validated by a spot-on Quantitative elemental analysis. Bulk (Please Ask quotes for large sizes). Prompt.
Northeast Business Center, 7301 E. 90th Street, Suite 117,Indianapolis, IN 46256, USA;
Tel: 317-598-0828, Toll-free: 1-877-343-6578 (US and Canada only);Fax: 317-598-0835; info@chemietek.com
Copyright © 2014 Chemietek. All Rights Reserved.